
        <!DOCTYPE html>
        <html>
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</title>
            <style>
                :root {
                    --primary-color: #2563eb;
                    --secondary-color: #0891b2;
                    --accent-color: #4f46e5;
                    --light-bg: #f3f4f6;
                    --border-color: #e5e7eb;
                    --text-color: #1f2937;
                    --text-light: #6b7280;
                }
                
                body {
                    font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
                    line-height: 1.6;
                    color: var(--text-color);
                    background-color: #ffffff;
                    margin: 0;
                    padding: 0;
                }
                
                .container {
                    max-width: 900px;
                    margin: 0 auto;
                    padding: 2rem;
                }
                
                header {
                    text-align: center;
                    margin-bottom: 2.5rem;
                    border-bottom: 2px solid var(--border-color);
                    padding-bottom: 1rem;
                }
                
                h1 {
                    color: var(--primary-color);
                    font-size: 2.5rem;
                    margin-bottom: 0.5rem;
                }
                
                .subtitle {
                    color: var(--text-light);
                    font-size: 1.2rem;
                    margin-top: 0;
                }
                
                section {
                    margin-bottom: 2.5rem;
                    background-color: white;
                    border-radius: 0.5rem;
                    box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
                    padding: 1.5rem;
                    border-left: 4px solid var(--primary-color);
                }
                
                h2 {
                    color: var(--primary-color);
                    font-size: 1.8rem;
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                h3 {
                    color: var(--secondary-color);
                    font-size: 1.3rem;
                    margin: 1.5rem 0 0.5rem;
                }
                
                ul, ol {
                    padding-left: 1.5rem;
                }
                
                li {
                    margin-bottom: 0.5rem;
                }
                
                .final-annotation {
                    background-color: #ecfdf5;
                    border-left: 4px solid #10b981;
                }
                
                .final-annotation h2 {
                    color: #10b981;
                }
                
                .iteration {
                    margin-bottom: 1.5rem;
                    background-color: var(--light-bg);
                    border-radius: 0.5rem;
                    padding: 1.5rem;
                    border-left: 4px solid var(--secondary-color);
                }
                
                .iteration-title {
                    font-size: 1.5rem;
                    color: var(--secondary-color);
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                .gene-list {
                    display: flex;
                    flex-wrap: wrap;
                    gap: 0.5rem;
                    margin: 1rem 0;
                }
                
                .gene-badge {
                    background-color: var(--accent-color);
                    color: white;
                    padding: 0.3rem 0.7rem;
                    border-radius: 1rem;
                    font-size: 0.9rem;
                    font-weight: 500;
                }
                
                .sub-section {
                    background-color: white;
                    border-radius: 0.3rem;
                    padding: 1rem;
                    margin-top: 1rem;
                }
                
                code {
                    font-family: ui-monospace, monospace;
                    font-size: 0.9em;
                }
                
                .marker-category {
                    margin-bottom: 1rem;
                }
                
                .marker-category-title {
                    font-weight: 600;
                    margin-bottom: 0.5rem;
                    color: var(--secondary-color);
                }
                
                .hypothesis-list {
                    display: flex;
                    flex-direction: column;
                    gap: 0.8rem;
                }
                
                .hypothesis-item {
                    padding-left: 1.5rem;
                    position: relative;
                    margin-bottom: 0.5rem;
                }
                
                .hypothesis-number {
                    position: absolute;
                    left: 0;
                    font-weight: 600;
                    color: var(--accent-color);
                }
                
                .hypothesis-item-continued {
                    padding-left: 1.5rem;
                    margin-top: -0.3rem;
                    color: var(--text-light);
                }
            </style>
        </head>
        <body>
            <div class="container">
                <header>
                    <h1>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</h1>
                    <p class="subtitle">Single-cell RNA-seq Analysis Report</p>
                </header>
                
                <section>
                    <h2>Overview</h2>
                    <div class="content">
                        This report summarizes an iterative gene expression analysis performed by CASSIA to annotate a specific cell cluster. The analysis involved 3 iterations, examining a total of 31 unique genes.
                    </div>
                </section>
                
                <section>
                    <h2>Initial Assessment</h2>
                    <div class="content">
                        The initial hypothesis was that the cells were IgA-secreting Plasma Cells, supported by a strong signature of immunoglobulin genes (IGHA1/2, JCHAIN) and plasma cell markers (JCHAIN, TNFRSF17, MZB1). Concerns were raised regarding the unusual presence of MYL2, and the high expression of IGLL5 and IGLV6-57, which could indicate contamination, doublets, or a transitional/mixed population.
                    </div>
                </section>
        
                    <section>
                        <h2>Iteration 1</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To confirm plasma cell identity and rule out B cell contamination: By checking classical B cell (CD19, CD20, MS4A1) and plasma cell (CD27, CD38, SDC1) surface markers, the aim was to see if high expression of plasma cell markers with low/absent B cell markers would support a mature plasma cell identity, or if co-expression would suggest a pre-plasma cell/plasmablast or mixed population.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To investigate the MYL2 anomaly: By checking markers for common non-immune cells (smooth muscle: ACTA2, TAGLN; T cells: CD3G, CD3D; macrophages: CD14, CD68), the goal was to identify potential contamination or doublets if MYL2 co-expressed with these markers.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To assess B-1 cell involvement: By examining B-1 specific markers (CD5, CD19, CD20, IGHM, IGHD, CD27), the aim was to determine if co-expression of CD5 with B cell markers would suggest a B-1 cell component or a B-1 derived plasma cell subset.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">CD19</span><span class="gene-badge">CD20</span><span class="gene-badge">MS4A1</span><span class="gene-badge">CD27</span><span class="gene-badge">CD38</span><span class="gene-badge">SDC1</span><span class="gene-badge">MYL2</span><span class="gene-badge">ACTA2</span><span class="gene-badge">TAGLN</span><span class="gene-badge">CD3G</span><span class="gene-badge">CD3D</span><span class="gene-badge">CD14</span><span class="gene-badge">CD68</span><span class="gene-badge">CD5</span><span class="gene-badge">IGHM</span><span class="gene-badge">IGHD</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                The analysis strongly supported plasma cell identity with high expression of CD27 and CD38, and absence of T-cell markers (CD3D, CD3G). MYL2 expression remained high without other smooth muscle markers. IGHM and CD5 were detected, suggesting potential heterogeneity. SDC1 expression was unexpectedly low for mature plasma cells.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 2</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To definitively rule out smooth muscle contamination: By checking a broader panel of smooth muscle markers (ACTA2, TAGLN, MYH11, DES) alongside MYL2, the aim was to confirm if MYL2 was part of a smooth muscle component or an isolated expression.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To re-evaluate plasma cell maturity and differentiation state: By examining a full spectrum of B cell to plasma cell differentiation markers, including transcription factors (XBP1, PRDM1) and surface markers (CD19, CD20, MS4A1, CD27, CD38, SDC1), the goal was to clarify if low SDC1 indicated a plasmablast/early plasma cell stage.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To further investigate B-1 cell involvement: By re-examining B-1 specific markers (CD5, CD19, CD20, IGHM, IGHD, CD43, CD27), the aim was to determine if co-expression of CD5 and CD43 with IGHM and plasma cell markers suggested a B-1 derived plasma cell.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">MYL2</span><span class="gene-badge">ACTA2</span><span class="gene-badge">TAGLN</span><span class="gene-badge">MYH11</span><span class="gene-badge">DES</span><span class="gene-badge">CD19</span><span class="gene-badge">CD20</span><span class="gene-badge">MS4A1</span><span class="gene-badge">CD27</span><span class="gene-badge">CD38</span><span class="gene-badge">SDC1</span><span class="gene-badge">XBP1</span><span class="gene-badge">PRDM1</span><span class="gene-badge">CD5</span><span class="gene-badge">IGHM</span><span class="gene-badge">IGHD</span><span class="gene-badge">CD43</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                High expression of XBP1 was observed, strongly supporting plasma cell differentiation. However, PRDM1 expression was low, which is unexpected for a typical plasma cell. MYL2 remained highly expressed without other smooth muscle markers. SDC1 remained low. IGHM and CD5 were still present in a minority of cells.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 3</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To clarify the contradictory XBP1/PRDM1 expression: By investigating key transcription factors (PRDM1, IRF4, BLIMP1, XBP1, PAX5, BCL6) involved in B cell to plasma cell differentiation, the aim was to understand if the high XBP1 and low PRDM1 indicated a specific differentiation pathway or early plasma cell stage.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To definitively address the MYL2 anomaly: By broadening the search for related genes (MYL9) and re-examining a comprehensive panel of smooth muscle markers (ACTA2, TAGLN, MYH11, DES), and checking for endothelial markers (CDH5), the goal was to determine if MYL2 was isolated or part of another cell type.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To re-evaluate plasma cell maturity and identity: By re-examining the full panel of B cell and plasma cell surface markers (CD19, CD20, MS4A1, CD27, CD38, SDC1, CD138, TNFRSF17), the aim was to confirm SDC1 levels and see if high CD27, CD38, and TNFRSF17 still supported plasma cell identity despite low SDC1.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">PRDM1</span><span class="gene-badge">IRF4</span><span class="gene-badge">BLIMP1</span><span class="gene-badge">XBP1</span><span class="gene-badge">PAX5</span><span class="gene-badge">BCL6</span><span class="gene-badge">MYL2</span><span class="gene-badge">MYL9</span><span class="gene-badge">ACTA2</span><span class="gene-badge">TAGLN</span><span class="gene-badge">MYH11</span><span class="gene-badge">DES</span><span class="gene-badge">CDH5</span><span class="gene-badge">CD19</span><span class="gene-badge">CD20</span><span class="gene-badge">MS4A1</span><span class="gene-badge">CD27</span><span class="gene-badge">CD38</span><span class="gene-badge">SDC1</span><span class="gene-badge">CD138</span><span class="gene-badge">TNFRSF17</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                Strong expression of TNFRSF17 (BCMA) was observed, further reinforcing plasma cell identity. BCL6 was detected, which is unusual for mature plasma cells. PRDM1 remained low, while XBP1 remained high. MYL9 was detected alongside MYL2, but other smooth muscle or endothelial markers were absent. SDC1 remained low.
                            </div>
                        </div>
                    </section>
                
                <section class="final-annotation">
                    <h2>Final Annotation</h2>
                    <div class="content">
                        The final annotation for this cluster is **Plasma Cell**. The confidence level is **high**.
                    </div>
                </section>
        
                    <section>
                        <h2>Key Marker Genes</h2>
                        <div class="content">
                            **Immunoglobulin Genes:** JCHAIN, IGHA1, IGHA2 (inferred from initial context)
**Plasma Cell Markers:** CD27, CD38, TNFRSF17, XBP1
**Transcription Factors:** XBP1 (high), PRDM1 (low)
**Anomalous Markers:** MYL2, MYL9
**B Cell Markers (present in minority/unexpected):** BCL6, IGHM, CD5
                        </div>
                    </section>
                
                    <section>
                        <h2>Recommendations</h2>
                        <div class="content">
                            No explicit recommendations for further steps or validation were provided in the final conclusion, beyond the internal reasoning of the iterative process.
                        </div>
                    </section>
                
            </div>
        </body>
        </html>
        